Francesco Salvo, MD, PhD

Department of Medical Pharmacology, Regional Pharmacovigilance Center of Bordeaux, University Hospital of Bordeaux, Inserm U1219, Université de Bordeaux, F-33000, Bordeaux, France

JCP
Dual Orexin Receptor Antagonists and Suicide Risk
Brief Report

September 27, 2023

According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on...
Francesco Salvo, Laura Palagini, Pierre A. Geoffroy

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe